Literature DB >> 21547378

Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson's disease.

Young Eun Kim, Han-Joon Kim, Ji Young Yun, Beom S Jeon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547378     DOI: 10.1007/s00415-011-6083-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

1.  Managing Parkinson's disease during surgery.

Authors:  K A Brennan; R W Genever
Journal:  BMJ       Date:  2010-11-01

2.  Successful perioperative management of patients with Parkinson's disease following gastrointestinal surgery: report of three cases.

Authors:  Takaaki Fujii; Toshihiro Nakabayashi; Shinji Hashimoto; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2009-09-24       Impact factor: 2.549

3.  Successful perioperative management of a patient with Parkinson's disease by enteral levodopa administration under propofol anesthesia.

Authors:  R Furuya; A Hirai; T Andoh; I Kudoh; F Okumura
Journal:  Anesthesiology       Date:  1998-07       Impact factor: 7.892

4.  Perioperative problems in Parkinson's disease and their management: apomorphine with rectal domperidone.

Authors:  N Gálvez-Jiménez; A E Lang
Journal:  Can J Neurol Sci       Date:  1996-08       Impact factor: 2.104

5.  Transdermal rotigotine for the perioperative management of Parkinson's disease.

Authors:  Ullrich Wüllner; Jan Kassubek; Per Odin; Michael Schwarz; Markus Naumann; Hermann-Josef Häck; Babak Boroojerdi; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

  5 in total
  2 in total

1.  Preliminary study of intravenous amantadine treatment for ataxia management in patients with probable multiple system atrophy with predominant cerebellar ataxia.

Authors:  Jinyoung Youn; Hyeeun Shin; Ji Sun Kim; Jin Whan Cho
Journal:  J Mov Disord       Date:  2012-05-30

2.  Effect of Repeated Intravenous Amantadine Infusions in Patients with Parkinson's Disease: An Open-Label Pilot Study.

Authors:  Alexander Khlebtovsky; Israel Steiner; Therese Treves; Ruth Djaldetti
Journal:  Clin Transl Sci       Date:  2019-09-24       Impact factor: 4.689

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.